These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3577156)

  • 1. [Theophylline pharmacokinetics in elderly persons and in patients with bronchial asthma or chronic obstructive bronchitis].
    Mazurek W; Halawa B
    Wiad Lek; 1986 Nov; 39(21):1451-6. PubMed ID: 3577156
    [No Abstract]   [Full Text] [Related]  

  • 2. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T; Józefczak E; Raczka A
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP; Kreukniet J; Drost RH; Maes RA
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The efficacy of theopek in bronchial asthma and chronic bronchitis].
    Korzh OB
    Ter Arkh; 1990; 62(3):82-4. PubMed ID: 2368005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nebetol in the treatment of bronchial asthma and chronic obstructive bronchitis].
    Popovac D; Spasić P; Vukcević G
    Plucne Bolesti; 1985; 37(1-2):106-9. PubMed ID: 3906721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Respiratory insufficiency and pharmacology of theophylline].
    Clozel JP; du Souich P
    Bull Eur Physiopathol Respir; 1982; 18(6):807-10. PubMed ID: 6927535
    [No Abstract]   [Full Text] [Related]  

  • 7. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of ranitidine on theophylline pharmacokinetics in patients with obstructive lung disease].
    Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V
    Plucne Bolesti; 1991; 43(1-2):89-93. PubMed ID: 1766997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial of proxyphylline in the treatment of chronic obstructive airways disease.
    Dinda P; Chatterjee SS; Riding WD; Singh T
    Br J Clin Pract; 1969 Dec; 23(12):505-7. PubMed ID: 5359446
    [No Abstract]   [Full Text] [Related]  

  • 10. [Theophylline in the serum and bronchoalveolar lavage fluid (BALF) in patients with bronchospastic conditions].
    Płusa T; Wasek Z; Kruszewski J; Józefczak E; Raczka A
    Pneumonol Pol; 1988 Nov; 56(11):523-7. PubMed ID: 3075272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic obstructive respiratory syndrome with the new theophylline preparation Afonilum retard].
    Dettmer HH
    Fortschr Med; 1981 Jul; 99(25):1007-11. PubMed ID: 7262783
    [No Abstract]   [Full Text] [Related]  

  • 12. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
    Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
    Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
    Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
    Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics of two theophylline derivatives in asthmatic patients.
    Jones RW
    J Int Med Res; 1979; 7 Suppl 1():16-21. PubMed ID: 374160
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased theophylline clearance in a patient with hyperthyroidism.
    Bauman JH; Teichman S; Wible DA
    Ann Allergy; 1984 Feb; 52(2):94-6. PubMed ID: 6696299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ketotifen on the eicosanoid system, immunoreactivity and bronchial patency in patients with obstructive pulmonary diseases].
    Efimov VV; Blazhko VI; Liashenko MM; Voeĭkova LS; Bondar' TN
    Ter Arkh; 1991; 63(3):70-3. PubMed ID: 1648274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of obstructive ventilation disorders].
    Günthner W; Krieger E
    Praxis; 1968 Nov; 57(45):1579-82. PubMed ID: 5757109
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with bamifylline in children with asthmatic bronchitis or bronchial asthma].
    Mora P; De Giorgis A; Brienza T; Farri A
    Minerva Pediatr; 1986 Feb; 38(3-4):119-23. PubMed ID: 3702843
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined beta-stimulator and theophylline therapy.
    Rosenhall L
    Eur J Respir Dis Suppl; 1980; 109():92-4. PubMed ID: 6108229
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced theophylline metabolism in patients with bronchial asthma at age 4 and under.
    Kizu J; Arakawa M; Arakawa Y; Komoda F; Takamizawa M; Iwata T; Hayakawa T; Imai K
    Biomed Chromatogr; 1999 Nov; 13(7):462-4. PubMed ID: 10534757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.